Overview
Lobbying Costs
100,000€ - 199,999€
Financial year: Jan 2023 - Dec 2023
Lobbyists (Full time equivalent)
2 Fte (2)
Lobbyists with EP accreditation
0
High-level Commission meetings
1
Lobbying Costs over the years
-
Info
Hologic BV
EU Transparency Register
991268442758-59 First registered on 13 May 2021
Goals / Remit
Hologic is an innovative medical technology company primarily focused on improving women’s health and well-being through early detection and treatment. With more than 6.500 employees all over the world, Hologic has a strong presence in many European countries, such as France, Italy, Germany or Spain. Hologic focuses on three key areas in women’s healthcare, which determine the three divisions of the organization: Diagnostic Solutions, Breast & Skeletal Health Solutions and GYN Surgical Solutions.
Main EU files targeted
o Fight Against Cancer
o Healthcare
o Sustainable Health Care
o Women's health
o Non-communicable diseases - Cancer
o Communicable diseases - STIs
o European Cancer Guidelines
o AI
o European Commission's annual work programme
o Pharmaceutical Industry Strategy
o Pharmaceutical Incentives and regulation
o Research policy & programmes
o Innovative Medicines Initiative (IMI)
o Vaccines EU policies
o Medical Devices Regulation
o European health data spaceAddress
Head Office
Hologic, Inc., 250 Campus Drive
Marlborough MA01752
UNITED STATESEU Office
172 rue de Charonne Le Dorian B2
PARIS 75011
FRANCEWebsite
-
People
Total lobbyists declared
2
Employment time Lobbyists 100% 2 Lobbyists (Full time equivalent)
2
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
Companies & groups
-
Networking
Affiliation
Medtech Europe, COCIR, Assobiomedica (Italy), Fenin (Spain), Medicorindustrien (DK), Swedishlabtech (SE), Swissmedtech (Switzerland), ABHI (UK), SIDIV (France), VDGH (Germany)
Member organisations
None declared
-
Financial Data
Interests represented
Promotes their own interests or the collective interests of their members
Closed financial year
Jan 2023 - Dec 2023
Lobbying costs for closed financial year
100,000€ - 199,999€
Major contributions in closed year
None declared
Intermediaries for closed year
Name Amount fipra 0€ - 10,000€ lysios 100,000€ - 199,999€ kreab 100,000€ - 199,999€ Intermediaries for current year
Name lysios kreab Closed year Costs
100,000€ - 199,999€
Other financial info
FIPRA 2023: Intelligence gathering EC on cervical cancer screening guidelines.
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
1 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.
-
Date 10 Apr 2024 Location Brussels Subject EU Women’s Health Strategy Cabinet Cabinet of Commissioner Helena Dalli Attending - Lesia Radelicki (Cabinet member)